Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?

IUBMB Life

Volumn 62, Issue 10, 2010, Pages 746-751

  Cavalieri, Ercole L ^a   Rogan, Eleanor G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

bisphenol A as carcinogen; catechol estrogen; catechol quinones; estrogens; molecular mechanism of cancer initiation

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATASE; CATECHOL; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; DIETHYLSTILBESTROL; ESTROGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; DNA ADDUCT; HUMAN; NONHUMAN;

CARCINOGENS; CATECHOL O-METHYLTRANSFERASE; DIETHYLSTILBESTROL; DNA; DNA ADDUCTS; ESTRADIOL; ESTROGENS; ESTROGENS, CATECHOL; ESTROGENS, NON-STEROIDAL; HUMANS; MUTATION; PHENOLS; QUINONES; TUMOR MARKERS, BIOLOGICAL;

HUMAN ECHOVIRUS 1;

EID: 79951989428     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.376     Document Type: Article

References (45)

1. vom Saal, F. S., Akingbemi, B. T., Belcher, S. M., Birmbaum, L. S., Crain, D. A., et al. (2007) Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels o (Pubitemid 47385099)
2. Calafat, A. M., Ye, X., Wong, Y.-L., Reidy, J. A., and, Needham, L. L., (2008) Exposure of the U.S. population to Bisphenol A and 4-tertiary- Octylphenol: 2003-2004. Environ. Health Perspect. 116, 39-44.
3. Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., and, Sutter, T., (2006) Catechol estrogen quinones as initiators of breast and other human cancers. Implications for biomarkers of susceptibility and cancer prevention. BBA-Rev. Cancer 1766, 63-78. (Pubitemid 44175632)
4. Cavalieri, E. L., and, Rogan, E. G., (2010) Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol. 6, 75-91.
5. Herbst, A. L., Ulfelder, H., and, Proskanzer, D. C., (1971) Adenocarcinoma of the vagina. Association of maternal silbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284, 878-881.
6. Saeed, M., Rogan, E., and, Cavalieri, E., (2009) Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int. J. Cancer 124, 1276-1284.
7. Miller, J. A., (1970) Carcinogenesis by chemicals: an overview-GHA Clowes memorial lecture. Cancer Res. 30, 559-576.
8. Miller, E. C., and, Miller, J. A., (1981) Searches for ultimate chemical carcinogenes and their reactions with cellular macromolecules. Cancer 47, 2327-2345. (Pubitemid 11127620)
9. Zhu, B. T., and, Conney, A. H., (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19, 1-27. (Pubitemid 28376821)
10. Cavalieri, E. L., Kumar, S., Todorovic, R., Higginbotham, S., Badawi, A. F., and, Rogan, E. G., (2001) Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem. Res. Toxicol. 14, 1041-1050. (Pubitemid 32800160)
11. Rogan, E. G., Badawi, A. F., Devanesan, P. D., Meza, J. L., Edney, J. A., West, W. W., Higginbotham, S. M., and, Cavalieri, E. L., (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24, 697-702. (Pubitemid 36592404)
12. Lu, F., Zahid, M., Saeed, M., Cavalieri, E. L., and, Rogan, E. G., (2007) Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J. Steroid Biochem. Mol. Biol. 105, 150-158. (Pubitemid 47211948)
13. Gaikwad, N. W., Muti, P., Meza, J., Yang, L., Pruthi, S., Ingle, J., Rogan, E. G., and, Cavalieri, E. L., (2008) The molecular etiology of breast cancer: evidence from biomarkers of risk. Int. J. Cancer 122, 1949-1957. (Pubitemid 351441183)
14. Gaikwad, N. W., Yang, L., Pruthi, S., Ingle, J. N., Sandhu, N., Rogan, E., and, Cavalieri, E., (2009) Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer: Basic Clin. Res. 3, 1-8.
15. Yang, L., Gaikwad, N., Meza, J., Cavalieri, E., Muti, P., Trock, B., and, Rogan, E., (2009) Novel biomarkers for risk of prostate cancer. Results from a case-control study. Prostate 69, 41-48.
16. Zahid, M., Saeed, M., Lu, F., Gaikwad, N., Rogan, E., and, Cavalieri, E. L., (2007) Inhibition of catechol-O-methyltransferase increases estrogen DNA-adduct formation. Free Radic. Biol. Med. 43, 1534-1540. (Pubitemid 47615397)
17. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., and, Rogan, E. G., (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94, 10937-10942. (Pubitemid 27430839)
18. Markushin, Y., Zhong, W., Cavalieri, E. L., Rogan, E. G., Small, G. J., Yeung, E. S., and, Jankowiak, R., (2003) Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem. Res. Toxicol. 16, 1107-1117. (Pubitemid 37163216)
19. Li, K.-M., Todorovic, R., Devanesan, P., Higginbotham, S., Kofeler, H., Ramanathan, R., Gross, M. L., Rogan, E. G., and, Cavalieri, E. L., (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25, 289-297. (Pubitemid 38239812)
20. Zahid, M., Kohli, E., Saeed, M., Rogan, E., and, Cavalieri, E., (2006) The greater reactivity of estradiol-3,4-quinone versus estradiol-2,3-quinone with DNA in the formation of depurinating DNA adducts. Implications for tumor-initiating activity. Chem. Res. Toxicol. 19, 164-172. (Pubitemid 43185475)
21. Markushin, Y., Gaikwad, N., Zhang, H., Kapke, P., Rogan, E. G., Cavalieri, E. L., Trock, B. J., Pavlovich, C., and, Jankowiak, R., (2006) Potential biomarker for early risk assessment of prostate cancer. Prostate 66, 1565-1571. (Pubitemid 44465821)
22. Chakravarti, D., Mailander, P., Li, K.-M., Higginbotham, S., Zhang, H. L., Gross, M. L., Meza, J. L., Cavalieri, E. L., and, Rogan, E. G., (2001) Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and form mutations in the H-ras gene. Oncogene 20, 7945-7953. (Pubitemid 34001555)
23. Mailander, P. C., Meza, J. L., Higginbotham, S., and, Chakravarti, D., (2006) Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101, 204-215. (Pubitemid 44573805)
24. Zhao, Z., Kosinska, W., Khmelnitsky, M., Cavalieri, E. L., Rogan, E. G., Chakravarti, D., Sacks, P. G., and, Guttenplan, J. B., (2006) Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem. Res. Toxicol. 19, 475-479.
25. Fernandez, S. V., Russo, I. H., and, Russo, J., (2006) Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int. J. Cancer 118, 1862-1868.
26. Russo, J., Hasan Lareef, M., Balogh, G., Guo, S., and, Russo, I. H., (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J. Steroid Biochem. Mol. Biol. 87, 1-25. (Pubitemid 37421335)
27. Lareef, M. H., Garber, J., Russo, P. A., Russo, I. H., Heulings, R., and, Russo, J., (2005) The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int. J. Oncol. 26, 423-429.
28. Russo, J., Fernandez, S. V., Russo, P. A., Fernbaugh, R., Sheriff, F. S., Lareef, H. M., Garber, J., and, Russo, I. H., (2006) 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 20, 1622-1634. (Pubitemid 44943799)
29. Lu, F., Zahid, M., Wang, C., Saeed, M., Cavalieri, E. L., and, Rogan, E. G., (2008) Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev. Res. 1, 135-145.
30. Liehr, J. G, Fang, W. F., Sirbasku, D. A., and, Ari-Ulubelen, A., (1986) Carcinogenicity of catecholestrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356.
31. Li, J. J., and, Li, S. A., (1987) Estrogen carcinogenesis in Syrian hamster tissue: role of metabolism. Fed. Proc. 46, 1858-1863. (Pubitemid 17075932)
32. Newbold, R. R., and, Liehr, J. G., (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60, 235-237. (Pubitemid 30070740)
33. Yue, W., Santen, R. J., Wang, J. P., Li, Y., Verderame, M. F., Bocchinfuso, W. P., Korach, K. S., Devanesan, P., Todorovic, R., Rogan, E. G., and, Cavalieri, E. L., (2003) Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J. Steroid Biochem. Mol. Biol. 86, 477-486. (Pubitemid 37412587)
34. Nakagawa, Y., and, Suzuki, T., (2001) Metabolism of bisphenol A in isolated rat hepatocytes and oestrogenic activity of a hydroxylated metabolite in MCF-7 human breast cancer cells. Xenobiotica 31, 113-123. (Pubitemid 32635340)
35. Jaeg, J. P., Perdu, E., Dolo, J., Debrauwer, L., Cravedi, J. P., and, Zalko, D., (2004) Characterization of new bisphenol A metabolites produced by CD1 mice liver microsomes and S9 fractions. J. Agric. Food Chem. 52, 4935-4942.
36. Qiu, S. X., Yang, R. Z., and, Gross, M. L., (2004) Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates. Chem. Res. Toxicol. 17, 1038-1046. (Pubitemid 39108673)
37. Edmonds, J. S., Nomachi, M., Terasaki, M., Morita, M., Skelton, B. S., and, White, A. H., (2004) The reaction of bisphenol A 3,4-quinone with DNA. Biochem. Biophys. Res. Commun. 319, 556-561. (Pubitemid 38725982)
38. Cavalieri, E. L., Li, K.-M., Balu, N., Saeed, M., Devanesan, P., Higginbotham, S., Zhao, J., Gross, M. L., and, Rogan, E., (2002) Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23, 1071-1077. (Pubitemid 34752965)
39. Zahid, M., Saeed, M., Rogan, E. G., and, Cavalieri, E. L., (2010) Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease. Free Radic. Biol. Med. 48, 318-324.
40. Saeed, M., Higginbotham, S., Gaikwad, N., Chakravarti, D., Rogan, E., and, Cavalieri, E., (2009) Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic. Biol. Med. 47, 1075-1081.
41. Saeed, M., Gunselman, S. J., Higginbotham, S., Rogan, E., and, Cavalieri, E., (2005) Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3′-4′-quinone or enzyme-activated 3′-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens. Steroids 70, 37-45. (Pubitemid 40029448)
42. Zhu, B. T., and, Liehr, J. G., (1996) Inhibition of catechol-O- methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin: possible role in estradiol-induced tumorigenesis. J. Biol. Chem. 271, 1357-1363.
43. Mannisto, P. T., and, Kaakola, S., (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical effects of new selective COMT inhibitors. Pharmacol Rev. 51, 593-628.
44. Abdo, K. M., Grumbein, S., Chou, B. J., and, Herbert, R., (2001) Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal. Toxicol. 13, 931-950. (Pubitemid 33020396)
45. Fernandez, S. V., and, Russo, J., (2010) Estrogen and xenoestrogens in breast cancer. Toxicol. Pathol. 38, 110-122.